When paired with oral legal peptides focused on recovery and muscle support, this stack becomes a dual-threat system: fat ...

Orion Corporation will publish its Financial Statement Release 2025 on Thursday, 12 February 2026. The publication dates of the Interim Reports and the Half-Year Financial Report in 2026 are as ...

Paris, le 18 juillet 2025. Sanofi annonce aujourd’hui la finalisation de l’acquisition de Blueprint Medicines Corporation (Blueprint). La nouvelle entreprise ajoute au portefeuille de Sanofi des médic ...

Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, ...

Clinical data from the OT‑101 P001 PDAC study suggest targeting TGFB2 merits additional evaluation in younger patients; in a treated subset characterized by low IL‑6, median OS was 12.7 months. † ...

Clinical data from the OT‑101 P001 PDAC study suggest that targeting TGFB2 merits additional evaluation in younger patients; in a treated subset characterized by low IL‑6, median OS was 12.7 months. † ...

This insider transaction follows prior purchases by other members of the board and the new leadership team and reflects growing alignment and confidence in the Company’s operational progress. Hapbee ...

The RSU awards and stock options were approved by Lifecore’s compensation committee and were granted as inducement equity awards in accordance with Nasdaq Listing Rule 5635 (c) (4) under the ...

Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the consortium of ...

Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. The facility, formerly ...

Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call ...

CARLSBAD, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing solutions, announced today the appointment of Chas McKhann to its ...